Thomas M Irwin JR MD John G Kimble MD Apmc
Thomas M Irwin JR MD John G Kimble MD Apmc was paid $3.01M by Medicaid between Jan 2018 and Jan 2023, across 43 billing codes. Its largest line is 31231, — 21% of everything it billed.
33Billing provider infoTHOMAS M IRWIN JR MD JOHN G KIMBLE MD APMC
MARRERO, LA 70072
MARRERO, LA 70072
33aNPI1124205133assigned 01/22/2008
33bProvider typeSpecialist
28Total paid$3.01M
24GClaims59,052
24DCodes billed43
24AFirst – last monthJan 2018 – Jan 2023
Compared with peers
Next to other Specialist providers in Louisiana
Rank by total paid#17 of 228
Median peer was paid$60K
This provider vs. median50×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,164 | $344K | |
| 2019 | 9,485 | $470K | |
| 2020 | 7,773 | $370K | |
| 2021 | 14,274 | $742K | |
| 2022 | 21,108 | $1.07M | |
| 2023 | 248 | $11K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 31231 | 21% | 7,543 | 6,989 | $633K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 15% | 1,864 | 1,382 | $452K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 11% | 7,495 | 7,002 | $335K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 11,511 | 10,297 | $321K |
| 86003 | 9.0% | 5,011 | 1,315 | $271K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 6.7% | 657 | 625 | $200K |
| 31237 | 3.7% | 490 | 379 | $113K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.1% | 2,109 | 1,904 | $95K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.9% | 860 | 799 | $88K |
| 70486 | 2.5% | 834 | 760 | $76K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.5% | 1,135 | 1,055 | $75K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 1.9% | 530 | 494 | $56K |
31 more codes
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.4% | 1,985 | $41K |
| 87581 | 1.3% | 2,204 | $39K | |
| 30140 | 1.3% | 278 | $38K | |
| 87486 | 1.1% | 2,531 | $32K | |
| 95117 | <1% | 2,784 | $19K | |
| 31575 | <1% | 350 | $19K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 732 | $17K |
| 92567 | <1% | 2,181 | $17K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 271 | $13K |
| 82785 | <1% | 964 | $12K | |
| 30117 | <1% | 65 | $9K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 51 | $7K |
| 92552 | <1% | 634 | $6K | |
| 95115 | <1% | 1,002 | $6K | |
| 69210 | <1% | 319 | $5K | |
| 92557 | <1% | 169 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 457 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 455 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 52 | $2K |
| 92556 | <1% | 128 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 258 | $1K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 167 | $1K |
| 99051 | <1% | 118 | $995.64 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 34 | $769.95 |
| 95024 | <1% | 39 | $602.22 | |
| 92555 | <1% | 64 | $486.38 | |
| 92587 | <1% | 14 | $366.43 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 581 | $300.73 |
| 86318 | <1% | 19 | $154.56 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 61 | $17.71 |
| 87631 | 0% | 46 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialIRWIN, THOMAS (MD)
| Provider | Location | Paid |
|---|---|---|
| QC Dental Docs, P.C. | Bettendorf, IA | $14K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.